Fundacion Zambrano

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Diabetic eye disease1 trial
• Macular degeneration1 trial

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• Apellis Pharmaceuticals, Inc.1 trial
• Oculis1 trial

Closed trials

• Completed

  A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)

  NCT06172257· Phase 3· Oculis· Source

• Completed

  An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

  NCT04770545· Phase 3· Apellis Pharmaceuticals, Inc.· Source